Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database

por Bagegni, Nusayba A., Tao, Yu, Ademuyiwa, Foluso O.
Publicado 2019

Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab

por Bagegni, Nusayba A, Davis, Andrew A, Clifton, Katherine K, Ademuyiwa, Foluso O
Publicado 2022

Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature

por Kruse, Megan L., Kang, Irene M., Bagegni, Nusayba A., Howell, W. Todd, Moore, Halle C. F., Bedell, Cynthia H., Stokoe, Christopher T.
Publicado 2021

Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors

por Bagegni, Nusayba A., Park, Haeseong, Kraft, Katlyn, O-Toole, Maura, Gao, Feng, Waqar, Saiama N., Ratner, Lee, Morgensztern, Daniel, Devarakonda, Siddhartha, Amin, Manik, Baggstrom, Maria Q., Liang, Chris, Selvaggi, Giovanni, Wang-Gillam, Andrea
Publicado 2022

Radiation-Induced Brachial Plexopathy in Patients With Breast Cancer Treated With Comprehensive Adjuvant Radiation Therapy

por Rudra, Soumon, Roy, Amit, Brenneman, Randall, Gabani, Prashant, Roach, Michael C., Ochoa, Laura, Prather, Heidi, Appleton, Catherine, Margenthaler, Julie, Peterson, Lindsay L., Bagegni, Nusayba A., Zoberi, Jacqueline E., Garcia-Ramirez, Jose, Thomas, Maria A., Zoberi, Imran
Publicado 2020

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

por Davis, Andrew A., Gerratana, Lorenzo, Clifton, Katherine, Medford, Arielle J., Velimirovic, Marko, Hensing, Whitney L., Bucheit, Leslie, Shah, Ami N., D'Amico, Paolo, Reduzzi, Carolina, Zhang, Qiang, Dai, Charles S., Denault, Elyssa N., Bagegni, Nusayba A., Opyrchal, Mateusz, Ademuyiwa, Foluso O., Bose, Ron, Gradishar, William J., Behdad, Amir, Ma, Cynthia X., Bardia, Aditya, Cristofanilli, Massimo
Publicado 2022